Association Between Beta-1 and Beta-2 Adrenergic Receptor Polymorphism and Beta-blocker(Bisoprolol) Therapy in Heart Failure.
Phase of Trial: Phase IV
Latest Information Update: 15 May 2012
At a glance
- Drugs Bisoprolol (Primary)
- Indications Chronic heart failure
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms ABBA
- Sponsors Merck KGaA
- 10 Jun 2017 Biomarkers information updated
- 13 Mar 2012 Additional lead trial centre/investigator identified as reported by ClinicalTrials.gov.
- 06 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.